Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Issue of Equity

25 Aug 2021 09:53

RNS Number : 7480J
Amati AIM VCT PLC
25 August 2021
 

Amati AIM VCT plc

25 August 2021

 

Amati AIM VCT plc (the "Company")

Legal Entity Identifier: 213800HAEDBBK9RWCD25

Issue of Equity

The Board of Amati AIM VCT plc (the "Company") is pleased to announce that on 23 August 2021 it allotted 4,158,772 new Ordinary Shares of 5p each in the capital of the Company ("Ordinary Shares") pursuant to the Offer for Subscription launched on 30 July 2021 (the "Offer"). In accordance with the terms and conditions of the Offer, the price at which 4,142,726 new Ordinary Shares were allotted, which was calculated by reference to the net asset value of an Ordinary Share on 19 August 2021, was 219.67p per Ordinary Share (net asset value divided by 0.99 to allow for issue costs of 1.0%) and the price at which 16,046 new Ordinary Shares were allotted, which was calculated by reference to the net asset value of an Ordinary Share on 5 August 2021, was 218.10p per Ordinary Share (net asset value divided by 0.99 to allow for issue costs of 1.0%)

As announced on 4 August 2021, the Offer is fully subscribed and currently closed for new applications unless and until the Board decides to utilise the over-allotment facility, in which case a further announcement will be made.

Applications have been made for the new Ordinary Shares to be admitted to the Official List of the FCA (with a Premium Listing) and to the London Stock Exchange for admission to trading on the main market for listed securities. It is expected that admission will occur and dealing will commence in the new Ordinary Shares on or around 31 August 2021.

As a result of the issue, the total number of Ordinary Shares in issue will be 137,072,218 and the total number of voting rights in the Company will be 137,072,218. This figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure Guidance and Transparency Rules.

For further information, please contact the investor line at Amati Global Investors on 0131 503 9115 or by email at info@amatiglobal.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEDKPBPFBKKDFB
Date   Source Headline
15th Jan 20247:00 amRNSIssue of Equity
12th Jan 20242:51 pmRNSNet Asset Value(s)
5th Jan 20245:29 pmRNSNet Asset Value(s)
3rd Jan 202412:44 pmRNSNet Asset Value(s)
2nd Jan 20241:58 pmRNSTotal Voting Rights
21st Dec 20233:45 pmRNSNet Asset Value(s)
20th Dec 20233:56 pmRNSTransaction in Own Shares
18th Dec 20237:00 amRNSNet Asset Value(s)
11th Dec 202311:01 amRNSNet Asset Value(s)
4th Dec 202310:44 amRNSNet Asset Value(s)
1st Dec 202310:25 amRNSTotal Voting Rights
30th Nov 20234:02 pmRNSDividend Declaration
28th Nov 202312:46 pmRNSTransaction in Own Shares
27th Nov 202312:16 pmRNSDirector/PDMR Shareholding
27th Nov 20239:34 amRNSIssue of Equity
24th Nov 20234:23 pmRNSNet Asset Value(s)
20th Nov 202310:19 amRNSNet Asset Value(s)
17th Nov 20234:46 pmRNSTransaction in Own Shares
13th Nov 20239:31 amRNSNet Asset Value(s)
6th Nov 202312:27 pmRNSTransaction in Own Shares
2nd Nov 20239:34 amRNSNet Asset Value(s)
1st Nov 202310:01 amRNSTotal Voting Rights
30th Oct 20233:52 pmRNSTransaction in Own Shares
30th Oct 202310:19 amRNSNet Asset Value(s)
23rd Oct 20234:50 pmRNSNet Asset Value(s)
19th Oct 202311:31 amRNSTransaction in Own Shares
16th Oct 202311:43 amRNSTransaction in Own Shares
13th Oct 20235:41 pmRNSNet Asset Value(s)
9th Oct 202312:54 pmRNSTransaction in Own Shares
6th Oct 20235:23 pmRNSNet Asset Value(s)
6th Oct 20237:01 amRNSDividend Declaration
6th Oct 20237:00 amRNSHalf-year Report
3rd Oct 202312:07 pmRNSNet Asset Value(s)
2nd Oct 202310:31 amRNSTotal Voting Rights
25th Sep 20239:53 amRNSNet Asset Value(s)
22nd Sep 20231:11 pmRNSTransaction in Own Shares
18th Sep 202312:10 pmRNSNet Asset Value(s)
14th Sep 202312:17 pmRNSTransaction in Own Shares
11th Sep 20239:21 amRNSNet Asset Value(s)
5th Sep 202311:24 amRNSCompliance with Market Abuse Regulation
4th Sep 202310:43 amRNSNet Asset Value(s)
1st Sep 202311:33 amRNSTotal Voting Rights
31st Aug 20234:44 pmRNSTransaction in Own Shares
25th Aug 20233:20 pmRNSNet Asset Value(s)
18th Aug 20235:18 pmRNSNet Asset Value(s)
15th Aug 20234:13 pmRNSTransaction in Own Shares
11th Aug 20234:20 pmRNSNet Asset Value(s)
4th Aug 20234:17 pmRNSNet Asset Value(s)
2nd Aug 20234:18 pmRNSTransaction in Own Shares
1st Aug 20234:49 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.